# Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

> **NCT00412516** · PHASE3 · COMPLETED · sponsor: **PATH** · enrollment: 519 (actual)

## Conditions studied

- Encephalitis, Japanese B

## Interventions

- **BIOLOGICAL:** Live attenuated SA 14-14-2 vaccine

## Key facts

- **NCT ID:** NCT00412516
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 519 (ACTUAL)
- **Last updated:** 2014-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412516, "Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00412516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*